PEE CEE COSMA SOPE
|
PEE CEE COSMA SOPE Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 39.47 | 9.40 | 6.37 | 18.01 | 7.96 |
| CEPS(Rs) | 45.52 | 15.10 | 8.86 | 20.23 | 10.78 |
| DPS(Rs) | 5.00 | 2.00 | 1.00 | 3.00 | 3.00 |
| Book NAV/Share(Rs) | 152.23 | 114.77 | 106.37 | 103.00 | 84.99 |
| Tax Rate(%) | 25.69 | 25.40 | 26.30 | 26.01 | 26.74 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.49 | 4.16 | 3.02 | 8.12 | 4.72 |
| EBIT Margin(%) | 10.74 | 3.38 | 2.97 | 8.12 | 4.14 |
| Pre Tax Margin(%) | 10.52 | 2.68 | 2.47 | 7.83 | 3.89 |
| PAT Margin (%) | 7.81 | 2.00 | 1.82 | 5.79 | 2.85 |
| Cash Profit Margin (%) | 9.01 | 3.21 | 2.53 | 6.51 | 3.86 |
| Performance Ratios | |||||
| ROA(%) | 22.18 | 5.33 | 4.09 | 14.19 | 6.93 |
| ROE(%) | 29.56 | 8.50 | 6.08 | 19.16 | 9.40 |
| ROCE(%) | 35.14 | 10.25 | 7.62 | 23.07 | 11.59 |
| Asset Turnover(x) | 2.84 | 2.67 | 2.25 | 2.45 | 2.43 |
| Sales/Fixed Asset(x) | 4.39 | 4.20 | 3.70 | 3.94 | 3.60 |
| Working Capital/Sales(x) | 10.97 | 20.20 | 38.52 | 18.85 | 9.72 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.23 | 0.24 | 0.27 | 0.25 | 0.28 |
| Receivable days | 1.43 | 1.71 | 1.81 | 1.57 | 1.75 |
| Inventory Days | 39.38 | 39.58 | 45.96 | 45.93 | 51.86 |
| Payable days | 8.37 | 6.07 | 10.63 | 11.57 | 9.91 |
| Valuation Parameters | |||||
| PER(x) | 9.93 | 10.53 | 19.31 | 6.19 | 5.60 |
| PCE(x) | 8.61 | 6.55 | 13.88 | 5.51 | 4.13 |
| Price/Book(x) | 2.57 | 0.86 | 1.16 | 1.08 | 0.52 |
| Yield(%) | 1.28 | 2.02 | 0.81 | 2.69 | 6.73 |
| EV/Net Sales(x) | 0.78 | 0.29 | 0.48 | 0.40 | 0.19 |
| EV/Core EBITDA(x) | 6.54 | 6.29 | 13.03 | 4.49 | 3.74 |
| EV/EBIT(x) | 7.27 | 8.54 | 16.15 | 4.88 | 4.66 |
| EV/CE(x) | 2.53 | 0.89 | 0.95 | 0.92 | 0.45 |
| M Cap / Sales | 0.78 | 0.21 | 0.35 | 0.36 | 0.16 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 7.33 | 34.33 | 12.69 | 11.24 | -2.76 |
| Core EBITDA Growth(%) | 179.04 | 67.56 | -53.04 | 90.74 | -20.55 |
| EBIT Growth(%) | 241.09 | 52.85 | -58.79 | 118.19 | -27.25 |
| PAT Growth(%) | 320.07 | 47.52 | -64.64 | 126.39 | -25.78 |
| EPS Growth(%) | 320.07 | 47.52 | -64.64 | 126.38 | -25.78 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.33 | 0.48 | 0.12 | 0.21 |
| Current Ratio(x) | 2.72 | 1.59 | 1.20 | 1.53 | 1.86 |
| Quick Ratio(x) | 0.78 | 0.15 | 0.23 | 0.15 | 0.81 |
| Interest Cover(x) | 47.90 | 4.81 | 5.90 | 28.00 | 16.28 |
| Total Debt/Mcap(x) | 0.01 | 0.39 | 0.41 | 0.11 | 0.41 |
Compare Financial Ratios of peers of PEE CEE COSMA SOPE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PEE CEE COSMA SOPE | ₹157.4 Cr | 5.8% | -0.8% | 71.6% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹553,152.0 Cr | -4% | -0.1% | -8.8% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹121,620.0 Cr | 2.6% | 8.9% | 1.6% | Stock Analytics | |
| DABUR INDIA | ₹93,214.9 Cr | 3% | 4.1% | -5.7% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹72,996.9 Cr | -2.5% | -3.3% | 6.7% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹47,878.3 Cr | 0.4% | -4.5% | -14.9% | Stock Analytics | |
PEE CEE COSMA SOPE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PEE CEE COSMA SOPE | 5.8% |
-0.8% |
71.6% |
| SENSEX | -1% |
-5% |
5.6% |
You may also like the below Video Courses
